- ICH GCP
- Registro de ensaios clínicos dos EUA
- Ensaio Clínico NCT04856462
Suporte culturalmente responsivo ao cuidador
Programa de Apoio Culturalmente Responsivo para Cuidadores Negros de Pessoas com Demência
Black family caregivers of older adults with Alzheimer's disease and/or related dementias (ADRD), have an increased mortality risk related to pre-existing health conditions and stress. Targeted, culturally responsive, health interventions that help Black ADRD caregivers to effectively manage their own health and use community preferenced ways of coping, can improve caregivers' overall health, perceived ability to provide care for a person with ADRD (self-efficacy), and increases the likelihood that they will experience benefits from caregiving. This clinical trial pilot will test the feasibility of a community based intervention designed to improve health outcomes for Black family caregivers of persons with ADRD.
Visão geral do estudo
Status
Condições
Intervenção / Tratamento
Descrição detalhada
The proposed intervention is a peer-supportive and facilitator-led video teleconference program that will engage small groups of caregivers weekly over 6 weeks. Each week participants (n = 36, 2-5/group) will receive a different culturally relevant caregiving or personal health strategy to practice. During the support calls, a facilitator will provide an overview of the content covered and each participant will have the opportunity to discuss their past week and how they engaged the weekly strategy, or challenges that came up for them during the week. The format will be structured to ensure that core content is reviewed, and everyone can be equally engaged while flexible enough that caregivers can receive support in the areas they need. A battery of assessment measures will be taken at weeks 1 and 8.
Tipo de estudo
Inscrição (Real)
Estágio
- Não aplicável
Contactos e Locais
Locais de estudo
-
-
Michigan
-
Ann Arbor, Michigan, Estados Unidos, 48109
- University of Michigan
-
-
Critérios de participação
Critérios de elegibilidade
Idades elegíveis para estudo
Aceita Voluntários Saudáveis
Gêneros Elegíveis para o Estudo
Descrição
Inclusion criteria for participation are as follows:
Self-identified as Black/ African American At least 18 years old Able to speak, understand, and hear spoken English Related to, or has a close personal relationship to a person over the age of 55 that has an ADRD diagnosis or evidence of cognitive impairment Regular access to a smartphone, tablet or computer with internet access that will allow video conferencing engagement.
Provides monitoring, and assistance in activities of daily living and or other care tasks for the care recipient.
-
Plano de estudo
Como o estudo é projetado?
Detalhes do projeto
- Finalidade Principal: Cuidados de suporte
- Alocação: N / D
- Modelo Intervencional: Atribuição de grupo único
- Mascaramento: Nenhum (rótulo aberto)
Armas e Intervenções
Grupo de Participantes / Braço |
Intervenção / Tratamento |
|---|---|
|
Experimental: Caregiver Support
All participants in all groups will receive 6 weeks of caregiving support including a weekly video/teleconference call, and handouts covering relevant educational topics) |
Caregivers engage in a weekly video/teleconference support group with a skilled facilitator to discuss various strategies for managing caregiving stress, challenging behaviors, and personal self-care. |
O que o estudo está medindo?
Medidas de resultados primários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Caregiver Self-efficacy for Obtaining Respite Care
Prazo: 6 weeks
|
Caregiver self-efficacy was measured using the Revised Scale for Caregiving Self-Efficacy at baseline and one week following the intervention. The scale assesses the level of confidence caregivers had in obtaining respite care, responding to disruptive behaviors, and controlling their own upsetting thoughts about caregiving, using a range of 0- 100, with 0 indicating not confident one could do the described task at all and 100 indicating certainty one could perform the described task. Outcomes report the average change from baseline. |
6 weeks
|
|
Caregiver Self-Efficacy for Controlling Upsetting Thoughts
Prazo: 6 Weeks
|
Caregiver self-efficacy was measured using the Revised Scale for Caregiving Self-Efficacy at baseline and one week following the intervention. The scale assesses the level of confidence caregivers had in obtaining respite care, responding to disruptive behaviors, and controlling their own upsetting thoughts about caregiving, using a range of 0- 100, with 0 indicating not confident one could do the described task at all and 100 indicating certainty one could perform the described task. Outcomes report the average change from baseline. |
6 Weeks
|
|
Caregiver Self-Efficacy for Responding to Disruptive Behaviors
Prazo: 6 Weeks
|
Caregiver self-efficacy was measured using the Revised Scale for Caregiving Self-Efficacy at baseline and one week following the intervention. The scale assesses the level of confidence caregivers had in obtaining respite care, responding to disruptive behaviors, and controlling their own upsetting thoughts about caregiving, using a range of 0- 100, with 0 indicating not confident one could do the described task at all and 100 indicating certainty one could perform the described task. Outcomes report the average change from baseline. |
6 Weeks
|
Medidas de resultados secundários
Medida de resultado |
Descrição da medida |
Prazo |
|---|---|---|
|
Positive Aspects of Caregiving
Prazo: 6 weeks
|
The Positive Aspects of Caregiving tool is a brief assessment measure that asks questions about caregiving experiences that made the caregiver feel good about providing care. Responses are rated from 1, disagree a lot, to 5, agree a lot. Scores range from 9 to 45 with higher scores indicating more positive experiences related to family caregiving. |
6 weeks
|
Colaboradores e Investigadores
Patrocinador
Colaboradores
Datas de registro do estudo
Datas Principais do Estudo
Início do estudo (Real)
Conclusão Primária (Real)
Conclusão do estudo (Real)
Datas de inscrição no estudo
Enviado pela primeira vez
Enviado pela primeira vez que atendeu aos critérios de CQ
Primeira postagem (Real)
Atualizações de registro de estudo
Última Atualização Postada (Real)
Última atualização enviada que atendeu aos critérios de controle de qualidade
Última verificação
Mais Informações
Termos relacionados a este estudo
Termos MeSH relevantes adicionais
Outros números de identificação do estudo
- HUM00230940
- 1K01AG065420-01A1 (Concessão/Contrato do NIH dos EUA)
Plano para dados de participantes individuais (IPD)
Planeja compartilhar dados de participantes individuais (IPD)?
Descrição do plano IPD
It is anticipated that the following data will be generated and made available 1) published tables, figures, graphs, and tables of data used for making graphs; 2) published journal papers, conference papers, annual reports and the final report; and 3) educational materials resulting from intervention development. All data will conform with relevant data and terminology standards.
Prazo de Compartilhamento de IPD
No less than 5 years following the date of the project completion or the date of study publication.
Critérios de acesso de compartilhamento IPD
To facilitate data sharing, project data will be made publicly available via a university-managed repository Deep Blue.
Tipo de informação de suporte de compartilhamento de IPD
- PROTOCOLO DE ESTUDO
- SEIVA
- ANALYTIC_CODE
- CSR
Informações sobre medicamentos e dispositivos, documentos de estudo
Estuda um medicamento regulamentado pela FDA dos EUA
Estuda um produto de dispositivo regulamentado pela FDA dos EUA
Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .